Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 12.55
-0.20 (-1.57%)
May 8, 2026, 11:22 AM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 50.81 million as of May 8, 2026. Its market cap has increased by 29.49% in one year.
Market Cap
50.81M
Enterprise Value
34.51M
Revenue
4.60M
Ranking
n/a
PE Ratio
57.26
Stock Price
12.55
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 50.81M, a decrease of -21.17%. That is a compound annual growth rate of -2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 50.81M | 27.53% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| ECO Animal Health Group | 63.36M |
| Ondine Biomedical | 62.35M |
| Abingdon Health | 54.17M |
| hVIVO | 51.53M |